Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German breast cancer DMP (disease management programme) backed by Schmidt:

This article was originally published in Clinica

Executive Summary

A new disease management programme (DMP) for the treatment of breast cancer in the German federal state of Baden-Wurrtemberg has received the tacit support of federal health minister Ulla Schmidt. The DMP, the result of an agreement between the Baden-Wurrtemberg hospitals' association, health insurance funds and doctors' association, focuses on offering treatment according to internationally accepted medical guidelines and standards. Ms Schmidt said that the opening of hospitals for outpatient treatment would play an important role in breast cancer care. The federal insurance department, which approves DMPs, has so far given the go-ahead for 186 programmes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel